Funding Rounds
Be Biopharma

Be Biopharma Series A round, October 2020

Be Biopharma

Be Biopharma is developing a proprietary class of engineered B cells as medicines in applications beyond cytotoxicity.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →